Statistical Geneticist

About the role: We are looking for a statistical geneticist to develop and test the underlying genetic score algorithms that underpin our web application. Qualifications: Ph.D. or Masters degree in a genetics-focused discipline Experience in genetics data analysis Experience in next-generation sequencing analysis Familiarity with variant databases, ClinVar, HGMD, Ensembl, gnomAD, 1kgenomes, etc. Familiarity with fastq to vcf-file analysis and processing, nf-core / sarek (preferred) Experience with GWAS and PRS modeling (preferred) Some programming knowledge, e.g. Python and R (preferred) Responsibilities: Combine common variant and rare variant genetic analysis approaches into algorithmic pipelines. Collect and integrate public data for testing genetic risk scoring models. Design accurate questions and tests to ensure the continuous improvement of our product. Work closely with the communications department to ensure accurate dissemination of genetic findings to our customers. Proactively collaborate with project teams to identify key needs and questions that can be addressed using genomics, sequencing, or bioinformatics. Benefits: Generous PTO Competitive salary and equity Comprehensive healthcare, dental, and vision plans 401k employee plan Technology stipends and office perks Our Mission Nucleus is redefining DTC genetic testing. By combining polygenic scores with traditional rare variant DNA analysis, the company provides comprehensive assessments of genetic disposition across a myriad of diseases and traits. Nucleus’ mission is to empower people to take agency over their health so no one dies from preventable disease - that’s why the company is building a platform based on cutting-edge science, where everyone has their genome in their pocket, complete clarity on their risks, and are empowered by personalized health measures. Nucleus is also bridging the gap between people, doctors, and scientists to help discoveries, therapies, and cures find their way to people faster. Learn more at mynucleus.com. Investors We’ve raised over $15m from investors across: Technology: Alexis Ohanian (Founder Reddit + 776), Founders Fund, Austen Allred (CEO, Bloom Institute of Technology), Matteo (CEO, Eight Sleep) Healthcare: Adrian Aoun (CEO, Forward Health), Brent Saunders (former CEO, Allergan), Patrick Hsu (Bioengineering Professor, UC Berkeley), Hugo Barra (CEO, Detect) Media: Night (Mr. Beast), Shrug Capital, Packy McCormick (Founder, Not Boring), Alexandra Botez (Chess influencer), Anthony Pompliano and many others.